#arnm

Health

The same technology that created COVID-19 vaccines is producing personalized cancer treatments. Moderna and Merck just published five-year results showing a 49% reduction in the risk of relapse. Oncology will never be the same.

Controversy

Health

The American HHS canceled funding for mRNA research through BARDA. The FDA rescinded its review of Moderna's mRNA flu vaccine. Researchers warn that political distrust of an already proven technology can delay the first cancer treatments that have been shown to reduce mortality by 49%.